chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Body aches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Breast cancer in December 2020, Surgery in December 2020 and Radiation therapy in December 2020. Concomitant products included METOPROLOL for an unknown indication.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced MYALGIA (Body aches). At the time of the report, MYALGIA (Body aches) outcome was unknown.            Patient also use other concomitant products along with metoprolol.  Treatment information was not provided.   This case was linked to MOD-2021-354326, MOD-2021-354380 (Patient Link).
One day post vax, pt experienced puffiness of left arm, pinkness at injection site and low grade fever onset.
she had the first two (Moderna) with her second dose of Moderna in May 2021 and currently on an OTC anti-inflammatory; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (she had the first two (Moderna) with her second dose of Moderna in May 2021 and currently on an OTC anti-inflammatory) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In May 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (she had the first two (Moderna) with her second dose of Moderna in May 2021 and currently on an OTC anti-inflammatory). At the time of the report, IMMUNISATION REACTION (she had the first two (Moderna) with her second dose of Moderna in May 2021 and currently on an OTC anti-inflammatory) outcome was unknown.            Concomitant product use was not provided by the reporter.  Patient was on OTC anti-inflammatory. Patient stated she wants to know how long she has to be off it before she can get the booster shot.   Reporter did not allow further contact
Developed ITP 3 weeks after vax. Had severe epistaxis and platelet count of 10k. Hospitalized and treated with IVIG.
Patient came to clinic for the second vaccine in her 2 dose COVID-19 vaccine series. Patient had received Moderna for her first dose, when patient arrived clerk gave the patient pfizer paper to complete. The LPN administered a dose of Pfizer before realizing the patient had received Moderna for her first dose. So patient has had one of each type of mRNA vaccine due to error.
A non-serious spontaneous report of we gave expired H1N1 to several patients was received from a registered nurse/health professional concerning an eight-year-old female out of 17 patients. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 15-Jan-2010. The original expiry date was 12-Feb-2010 which was changed. On 20-Jan-2010, the patient received H1N1, Intranasal. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved.
Information has been received from a physician concerning a 6 month old male who on approx 27Jul06 was vaccinated PO with the first dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human bovine). It was unk if medical attention was sought. At the time of this report, no adverse reaction was noted. Additional information has been requested.
Blood noted in diaper (orange coloration); Cath urine negative for blood or signs of infection.
Chest pain, chills, headache, sore throat, weakness, joint pain, muscle pain (at the site of injection). Treatment: Acetaminophen 1000 mg (1 g)
Administered Pfizer BioNtech Covid-19 Vaccine instead of Pfizer Bivalent vaccine
About 7 days later bigger, bigger around the injection site and  I took antibiotics. I took pictures of the area looked like the size of golf ball.
round rash the size of a donut; Itchy; red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (round rash the size of a donut), INJECTION SITE PRURITUS (Itchy) and INJECTION SITE ERYTHEMA (red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (red). On 03-Feb-2021, the patient experienced INJECTION SITE RASH (round rash the size of a donut) and INJECTION SITE PRURITUS (Itchy). At the time of the report, INJECTION SITE RASH (round rash the size of a donut), INJECTION SITE PRURITUS (Itchy) and INJECTION SITE ERYTHEMA (red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 54-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 19Oct2022 as dose 5 (booster), single (Lot number: GH9702) at the age of 53 years for covid-19 immunisation; bnt162b2 (BNT162B2), on 25Mar2021 as dose 1, single (Lot number: ER8727), on 15Apr2021 as dose 2, single (Lot number: EW0162), on 05Nov2021 as dose 3 (booster), single (Lot number: FF2593) and on 10May2022 as dose 4 (booster), single (Lot number: FP4554) for covid-19 immunisation. The patient's relevant medical history included: "high bp" (unspecified if ongoing), notes: but controlled w/ medication; "high cholesterol" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN, start date: Jan2021; METOPROLOL SUCCINATE, start date: Jan2021; PRILOSEC [OMEPRAZOLE], start date: Jan2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19 with Paxlovid from 20Oct2023 to 24Oct2023.
Patient developed fluttering in chest that improved, and then worsened with midsternal chest pain that was sharp and rated 3/10.
Information has been received from a physician and the nurses at the physician's office indicating that the GARDASIL "hurts more". Additional information is not expected.
pt states that about 30 minutes after getting the vax her heart started racing and fluttering so she took her bayer aspirin and went to bed.  This lasted about 30 minutes total.  Next day she had a headache and sore arm.  She no longer has any symptoms.  Pt wanted to make a note of her size since she only 4'11" and weighs 97 lbs and doesnt do well taking any medication.
congestion; dry cough; sore throat; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Sep-2021 and was forwarded to Moderna on 06-Sep-2021.    This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (congestion), COUGH (dry cough) and OROPHARYNGEAL PAIN (sore throat) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (congestion), COUGH (dry cough) and OROPHARYNGEAL PAIN (sore throat). At the time of the report, NASAL CONGESTION (congestion), COUGH (dry cough) and OROPHARYNGEAL PAIN (sore throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was reported No treatment Drug was reported
This spontaneous report was received from a medical assistant refers to a patient of unknown age. The medical assistant reported that 10 patients were inadvertently vaccinated with PNEUMOVAX 23 during an unspecified 3 week period that had been improperly stored. Additional information has been requested.
I received my 1st dose vaccine on Sunday, April 18th at 12:00pm. I started to show some uncomfortable symptoms on Tuesday, April 20th around mid-morning. It started with a bad headache and tiredness. By the evening on 4/20/2021 my eyes were sore, my head was pounding, I was extremely tired - just all around feeling unwell. Slept all night. Woke up this morning (4/21/2021) with a continued headache, sore eyes and feeling dizzy and very tired. This is still happening as I fill this form out (10:10am / 4/21/2021)
Bronchitis; This spontaneous case was reported by a consumer and describes the occurrence of BRONCHITIS (Bronchitis) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BRONCHITIS (Bronchitis). At the time of the report, BRONCHITIS (Bronchitis) outcome was unknown.            Concomitant medications were not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow-up received, contains no new information.
This was a Moderna booster. I woke up the following morning (11/12/2021) and the right side of my face was completely blown up, hard and so sore that I could not chew. I also had chills and severe body aches. These symptoms persisted until the morning of 11/15/2021, when my face finally returned to normal.
Narrative: COVID infection following COVID vaccine series 01/04, Pfizer, dose #1 01/25, Pfizer, dose #2 10/20, Pfizer, dose #3 09/14 COVID swab, result: detected 09/16 pt cc: cough, diarrhea, rhinorrhea, sore throat exposure: unknown
Vaccine at 0900 a.m.  At night, fever from 102 to 104 degrees F.  Developed cough, wheeze, respiration distress.  Sent by 911 to emergency department for wheezing.
This spontaneous report as received from a nurse refers to a patient of unknown age. The patient was subcutaneously vaccinated with lot # (667741/0811Z), Exp Date (10-JUN-2012), 0.5 ml MMR II (dose number was unspecified) on 19-JUL-2012. No other co-suspects were reported. No concomitant medications were reported. It was reported that on19-JUL-2012 the patient was inadvertently administered MMR II that had expired on 10-JUN-2012. No adverse effects reported. It was unspecified whether the patient had sought medical attention or not. The outcome were unknown. This is one of several reports received from the same source. Additional information is not expected.
Information has been received from a pharmacist concerning an 81 year old male who on Nov 04 2004 was vaccinated Im in the deltoid with a first dose of pneumococcal 23v polysaccharide vaccine (lot 649732/0513P). That evening, the patient began feeling pain behind his shoulders in the shoulder blade area on both sided, not only the side the vaccine was given. The patient reported that the pain became progressively worse. He was instructed by a physician to take over the counter pain medication and to apply heat. The pharmacist noted that there was no evidence of local swelling or pain at the injection site. The patient said the pain is still present on Nov 17 2004 and some nights he had difficulty sleeping. No product quality complaint was involved. Follow up information from the pharmacist indicated that the shoulder blade pain was due to the patient falling down an not the pneumococcal 23v polysaccharide vaccine (lot 649732/0513P). The patient has dementia and had actually fallen. The pain is not from the vaccine. The patient recovered. There were no problems with any other patients and pneumococcal 23v polysaccharide vaccine. Additional information is not expected.
Sudden loss of taste 3 months after 2nd vaccine dose. I had started a new supplement (GI Revive) at that time. Stopped taking it and loss of taste persists to this day.
Arm soreness at the site of the reaction that peaked approximately 12 hours after injection; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP 6955) via an unspecified route of administration in the right arm on 01Apr2021 at 09:15 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and sulfonamides allergy. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA), mineral nos, vitamin nos (CENTRUM ADULT) and lactobacillus nos (CULTURELLE), all from unknown dates and for unknown indications. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL 3247) via an unspecified route of administration in the left arm on 11Mar2021 at 09:45 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 01Apr2021, the patient experienced arm soreness at the site of the reaction that peaked approximately 12 hours after injection. The patient did not receive any treatment for the reported event. The adverse event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event arm soreness at the site of the reaction was recovered on an unknown date in Apr2021.   No follow-up attempts are possible. No further information is expected.
Date and time adverse event started: 3/26/21, 0800 Adverse events experienced and are they still occurring now:  syncope, headache What happened as a result of the adverse event? (doctor visit, ED or urgent care visit, hospitalization, life threatening illness, disability/permanent damage, death, none of these): Recommended Tylenol or ibuprofen for headache and to stay hydrated as well as continuing to rest. In addition, if symptoms worsen, advised to see primary provider.
This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Shingles vaccine for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown. It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine. Additional case details were reported as follows: The reporter was patient's friend. The age at vaccination was not reported. The reporter stated that his or her friend got a shingles vaccine and had a very painful attack that lasted a month. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required. This case has been linked with US2021AMR201252, reported by same reporter. Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201252: tag at post.
NONE GAVE EXIPIRED COVID 19: EXPIRED 11/22/2022 GIVEN: 12/19/2022
The morning after he woke up screaming at 3 am. The same day, he was in a trance. He would look at the ceiling for hours, and no response. He would not eat or drink anything. He wasn't mumbling anymore.
On 5/11/21, Pharmacist administered 1st dose Pfizer COVID 19 vaccine to Patient. Mom attested online and on consent from that patient's DOB made him 16 yrs old. Later, upon processing vaccine through his insurance, pharmacist discovered that his DOB is actually in the following year. Even though the agency has approved emergency use in age 12-15 on 5/10/21, our company has not allowed vaccination to this age group until state, and corporate approves it. Pharmacist verified all info with mom and mom attested to his DOB before vaccine was administered. Later, mom apologized via phone and admitted she made the mistake because she has another child with same birth month and day but different year; mom was confused. Rx incident was reported on our company website but we were also required to submit a VAERS per company policy.
fussy, loss of appetite, fever as high as 102.9 after having pneumococal conjugate and hepA vaccines on 6/23/08.
pt reported a few hours after vaccine was administered, she developed hives. Also felt sick and weak.
Patient got his booster vaccine three months too early. Patient did not complain of any adverse effects during the clinic.
Dizziness THROAT FELT TIGHT Narrative:  Anaphylactic reaction to injectable medication in past (gadolinium contrast)
Information has been received from a nurse practitioner concerning a 38 year old female teacher with no part medical history and no known drug allergies who was vaccinated on the morning of 4/25/02 IM in the left deltoid with a second dose of hep B vaccine recombinant. Concomitant therapyincluded diazepam. There was no illness at the time of vaccination. The pt "woke up the next morning and felt like she had the flu." It was reported that the symptoms lasted for 24 to 36 hrs then "went away without treatment." Follow-up info received from the nurse practitioner indicated that on 4/25/02, in the evening, the pt developed "flu like symptoms" which included headache, chills and body aches. The pt recovered on 4/27/02. Additional info is not expected.
patient woke up on 6/17/19 not feeling well, then noticed a lot of redness on his injected arm. When he went to the medical facility, the nurse practioner diagnosed him with cellulitis. she gave him a 10 day course of cephalexin.
Patient hospitalized due to breakthrough covid-19 infection on 7/19/21 and is still hospitalized pending  weaning  oxygen requirement. Patient completed Pfizer vaccination series in February.  Information below is from patient progress note (8/01/21):  Acute hypoxic respiratory failure 2/2 to COVID 19 PNA  Severe Sepsis on admission due to above - Pfizer vaccine, 2 doses completed in February   - COVID positive  - CXR patchy airspace opacities on both lungs  - CRP 187, Fibrinogen 472, Vit D 15.5, procalcitonin 0.54   - HFNC > 6L > 5L Nasal cannula , wean as tolerated  - Legio/strep pna negative  -  Ipatropium PRN  - Vitamin D-calcium supplement  - Dexametasone 6 mg daily completed  - Lovenox daily   IDDM  - Poorly controlled DM - A1C 10.5%  - Lantus 20 units QHS and Novolog 15U TID - ISS  - Accucheck at goal     HTN - ACEI hold initially due to hyperkalemia  - BP controlled  - HCTZ 25 mg daily   Hyponatremia/hyperkalemia - resolved - 136   COPD - Ipatropium PRN  - Not at home oxygen    HLD Resume statin    Chronic Pain Methadone 5 mg TID   PT/OT ordered Home oxygen exertion test today
A non-serious spontaneous report of a patient received expired FLUMIST and flu-like symptoms has been received from a health professional concerning an 11-year-old male, subsequent to FLUMIST. The patient's medical history included flu-like symptoms in the past with flu shots. No concomitant medications were reported. The patient received the expired FLUMIST on 27-Dec-2010. The vaccine expired on 06-Dec-2010. The mother stated that she was sure that the FLUMIST was effective because the patient developed flu-like symptoms as he did with past flu shots. The reporter offered to revaccinate the patient; however the mom seemed convinced that the dose he received was effective and did not want him to develop flu-like symptoms again. The patient was seen at subsequent visits and no longer had the symptoms. The outcome of both the events was resolved. Additional information was received on 24-Mar-2011 incorporated in the narrative: patient's medical history, adverse events and the outcome.
2 days after MMRV (PROQUAD and VZ) on (L) thigh developed progressively increasing redness at inj. site with local swelling. No itching, pain, inflammation, fever. Also had limp x 1 day. Final size 16 cm x 11.5 cm area of redness and fullness. Resolved.
started creating knots in my nexk; pain shooting down my left arem all the way to the elbow; muscle soreness; pain shooting down my left arem all the way to the elbow; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Sep-2021 and was forwarded to Moderna on 01-Sep-2021.    This spontaneous case was reported by a consumer and describes the occurrence of NECK MASS (started creating knots in my nexk), VACCINATION SITE PAIN (pain shooting down my left arem all the way to the elbow), MYALGIA (muscle soreness) and ARTHRALGIA (pain shooting down my left arem all the way to the elbow) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NECK MASS (started creating knots in my nexk), VACCINATION SITE PAIN (pain shooting down my left arem all the way to the elbow), MYALGIA (muscle soreness) and ARTHRALGIA (pain shooting down my left arem all the way to the elbow). At the time of the report, NECK MASS (started creating knots in my nexk), VACCINATION SITE PAIN (pain shooting down my left arem all the way to the elbow), MYALGIA (muscle soreness) and ARTHRALGIA (pain shooting down my left arem all the way to the elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product was not provided by the reporter  Treatment information was not provided